Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03848962 · ClinicalTrials.gov registry record

Collection and Distribution of Biospecimens for Novel Research Uses

A clinical trial of Healthy and Cancer, sponsored by iSpecimen.

Recruiting
Registry status
10,000
Enrollment target
2
Study locations

NCT03848962 is a study of Healthy and Cancer that is actively recruiting participants, run by iSpecimen. The registered enrollment target is 10,000 participants, above the 638-participant average among 1,090 other Healthy trials with a reported enrollment target (1467% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03848962, a study of Healthy and Cancer, is actively recruiting participants, sponsored by iSpecimen.

RECRUITING
Registry status
10,000 participants
Enrollment target
2
Study locations

Study Summary

iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnostic test and instrumentation development and validation; therapeutics development; other medical research including the impact that various specimen collection and handling methods and conditions have on research results; and in education such as researcher or physician training (collectively "research").

Study Locations (2)

Alabama

  • iSpecimen - Huntsville

Massachusetts

  • iSpecimen - Lexington

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2016-06-30
Est. Completion 2026-12-31

Sponsor

iSpecimen

1 total trials

What the Registry Record Tells You About NCT03848962

The ClinicalTrials.gov registry entry for NCT03848962 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 638-participant average among 1,090 other Healthy trials with a reported enrollment target (1467% higher). The listed sponsor is iSpecimen, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT03848962 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03848962 about?

NCT03848962 is a clinical study titled "Collection and Distribution of Biospecimens for Novel Research Uses". iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnos...

What is the current status of trial NCT03848962?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2016-06-30. Estimated completion is 2026-12-31.

What conditions does trial NCT03848962 study?

This clinical trial studies the following conditions: Healthy, Cancer, Autoimmune Diseases, Infectious Disease, Gastrointestinal Complication.

Who is sponsoring clinical trial NCT03848962?

This trial is sponsored by iSpecimen, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03848962 being conducted?

This trial has 2 study locations across Alabama, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.